| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 16.339 | 126.378 | 223.540 | 207.148 |
| Total Income - EUR | - | - | - | - | - | - | 16.340 | 126.379 | 223.541 | 207.151 |
| Total Expenses - EUR | - | - | - | - | - | - | 23.322 | 106.820 | 253.433 | 239.611 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -6.983 | 19.559 | -29.892 | -32.460 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -6.999 | 18.320 | -32.128 | -32.460 |
| Employees | - | - | - | - | - | - | 2 | 3 | 5 | 5 |
Check the financial reports for the company - Medmind S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 2.233 | 20.973 | 39.530 | 22.308 |
| Current Assets | - | - | - | - | - | - | 8.591 | 16.944 | 26.541 | 14.057 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 178 | 7.770 | 22.102 | 9.144 |
| Cash | - | - | - | - | - | - | 8.412 | 9.174 | 4.440 | 4.914 |
| Shareholders Funds | - | - | - | - | - | - | -6.958 | 11.340 | -20.822 | -53.165 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 17.782 | 28.709 | 87.294 | 89.757 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medmind S.r.l.